Brookline Capital Management Weighs in on Adial Pharmaceuticals, Inc.'s Q1 2024 Earnings (NASDAQ:ADIL) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) – Equities research analysts at Litchfield Hills Research upped their Q2 2023 earnings per share estimates for Adial Pharmaceuticals in a report released on Thursday, May 18th. Litchfield Hills Research analyst T. O’neill now expects that the company will post earnings of ($0.09) per share for the quarter, […]